Submitted by Anonymous (not verified) on 16 July 2025 - 16:06
Human medicines European public assessment report (EPAR): Ozempic, semaglutide, Date of authorisation: 08/02/2018, Revision: 17, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Ozempic, semaglutide, Date of authorisation: 08/02/2018, Revision: 17, Status: Authorised